Explore the full record of transactions filed by Venkatesan Jay, Directeur. Director active across 3 companies, notably ALPINE IMMUNE SCIENCES, INC.. Cumulatively, 13 reports have been published. Total volume traded: €6.9m. The latest transaction was filed on 9 February 2021 — X. Regulator: SEC (Form 4). All data is accessible without signup.
Jay Venkatesan is a Director at Alpine Immune Sciences, Inc. and Angion Biomedica Corp. He brings his expertise to the board, contributing to the strategy and direction of both companies.